| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC0771 |
| Trial ID | ChiCTR1800019170 |
| Disease | B-Cell Malignancy |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | A single-center, single-arm, open-label, dose escalation study to evaluate the safety & preliminary anti-tumor activity of CD19 allogeneic chimeric antigen receptor T cells (CD19 Allo-CAR-T) for the treatment of patients with relapsed / refractory B cell malignancies |
| Year | 2018 |
| Country | China |
| Company sponsor | Tianjin First Central Hospital |
| Cohort 1 | |||||||||
|
|||||||||